CRP Sante

CRP Sante, now known as Luxembourg Institute of Health, is a public biomedical research organization and a venture capital firm that invests in the development of new diagnostics. Founded 1988 in Strassen, Luxembourg, it typically invests in early stage ventures. On Jun 10, 2010, the company invested in Complix, a biopharmaceutical company in Belgium developing Alphabodies, a novel class of biopharmaceuticals. The company invested $6.2M in its Series A round.

The firm focuses on the development of new diagnostics, preventive strategies, innovative therapies and clinical applications that impact the healthcare of Luxembourgish and European citizens.